A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Vacaville facility a standout in Lonza earnings report - The Vacaville Reporter
Vacaville facility a standout in Lonza earnings report The Vacaville Reporter
Lonza lifts forecast as performance rebounds under new strategy - The Pharma Letter
Lonza lifts forecast as performance rebounds under new strategy The Pharma Letter
Lonza tops core profit forecast driven by main drug manufacturing business - Reuters
The logo of Swiss contract drug maker Lonza is seen at its headquarters in Basel, Switzerland October 1, 2020. REUTERS/Arnd Wiegmann/File Photo Purchase Licensing Right...
CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling - Fierce Pharma
CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling Fierce Pharma
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing - Pharmaceutical Technology
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing Pharmaceutical Technology
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge - BioSpectrum Asia
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge BioSpectrum Asia
Strategic planning in ADC development: insights from Lonza - Drug Target Review
Strategic planning in ADC development: insights from Lonza Drug Target Review
Lonza chooses TRU Global Solutions for cleanroom services - Cleanroom Technology
Lonza chooses TRU Global Solutions for cleanroom services Cleanroom Technology
Earnings call transcript: Lonza Confirms Strong 2025 Outlook in Q1 2025 - Investing.com
Earnings call transcript: Lonza Confirms Strong 2025 Outlook in Q1 2025 Investing.com
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy? - Nasdaq
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy? Nasdaq
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs - PharmTech.com
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs PharmTech.com
Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology
Ethris and Lonza focus on mRNA respiratory condition vaccines Pharmaceutical Technology
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - BioSpace
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention BioSpace
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines - Contract Pharma
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines Contract Pharma
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - GEN - Genetic Engineering and Biotechnology News
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention GEN - Genetic Engineering and Biotechnology News
Catching up with Lonza Capsules and Health Ingredients - Nutritional Outlook
Catching up with Lonza Capsules and Health Ingredients Nutritional Outlook
Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing - DCAT Value Chain Insights
Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing DCAT Value Chain Insights
Lonza Implements Streamlined Operating Model - Contract Pharma
Lonza Implements Streamlined Operating Model Contract Pharma
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page